New Search

If you are not happy with the results below please do another search

2034 search results for:

282

Production of RNA chips significantly simplified

Researchers at the Faculty of Chemistry at the University of Vienna have demonstrated a new method whereby commercially available DNA chips (microarrays) can be quickly and easily converted into RNA chips, which are otherwise much more difficult to produce. Such RNA microarrays help to elucidate the still unknown functions of RNA molecules in cells – […]

284

Beckman Coulter and Scopio Labs partner to accelerate adoption of haematology digital cell morphology platform

Beckman Coulter, a global leader in clinical diagnostics, and Scopio Labs, a MedTech company that develops AI-powered workflow solutions, have established a worldwide partnership to accelerate adoption of Scopio’s next generation peripheral blood smear platforms. Scopio’s technology employs full-field imaging and AI decision support to eliminate manual microscopy, while providing laboratory professionals and clinicians a […]

286

Coriolis Pharma to build new campus in Martinsried-Munich

Coriolis Pharma, a globally operating contract research and development organization (CRDO) and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, ATMP´s and vaccines, is expanding its current headquarters to form a new campus as the next step in its growth strategy.

287

Lifespin to collaborate wth Biobank Graz to expand database of metabolic profiles for novel oncology diagnostics platform

Regensburg, Germany-based Lifespin, has entered a collaborative agreement with Biobank Graz and the Clinical Division of Oncology of the Medical University of Graz to expand its database of metabolic human health profiles in the field of oncology. Under the agreement, Lifespin will be able to analyze and capture the metabolic profiles from more than 25,000 […]

288

Medix Biochemica acquires Bioresource Technology

Medix Biochemica has acquired 100 percent of the shares of Bioresource Technology (BRT) to broaden its base matrix capabilities and further strengthen its local presence in the US market. As a result of this partnership, Medix Biochemica will provide its customers with a comprehensive offering of raw materials for their IVD quality control products. The […]

289

Ixaka and Minaris Regenerative Medicine sign tech transfer, manufacturing agreement for cell therapy candidate REX-001

Ixaka, an integrated cell and gene therapy company, and Minaris Regenerative Medicine, a leading contract development and manufacturing service provider for the cell and gene therapy industry, have signed an agreement to enable technology transfer as well as clinical and commercial manufacture of REX-001, Ixaka’s lead autologous multi-cell therapy (MCT) being developed for the treatment […]

290

CardiNor inks US distribution agreement with IBL-America for the CardiNor Secretoneurin ELISA test

Cardiovascular DX company CardiNor AS has signed an exclusive agreement with IBL-America for sales of the CardiNor Secretoneurin ELISA test in the US. By initially targeting research institutes, clinical research organisations and pharmaceutical companies, CardiNor aims to spread awareness of this important new frontline biomarker and pave the way for future commercialisation upon US regulatory […]